Ferrous sulfate 325 mg 65 mg iron tablet
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Ferrous Sulfate 325 mg Tablets: Efficacy, Dosage, and Interactions
Introduction to Ferrous Sulfate 325 mg Tablets
Ferrous sulfate 325 mg tablets, containing 65 mg of elemental iron, are commonly prescribed for the treatment of iron deficiency anemia. This article synthesizes research findings on the efficacy, optimal dosing schedules, and potential drug interactions associated with ferrous sulfate.
Efficacy of Ferrous Sulfate in Treating Iron Deficiency
Comparative Efficacy in Chronic Kidney Disease (CKD) Patients
A study comparing ferric citrate and ferrous sulfate in patients with moderate to severe CKD found that ferric citrate led to a greater increase in transferrin saturation (TSAT) and ferritin levels over 12 weeks compared to ferrous sulfate. Despite this, ferrous sulfate remains a widely used treatment due to its availability and cost-effectiveness.
Iron Supplementation in Pregnancy
Research comparing once daily versus twice daily dosing of ferrous sulfate in pregnant women found that both regimens were effective in preventing iron deficiency anemia. However, the twice daily dose resulted in more side effects, suggesting that a once daily dose of 65 mg elemental iron may be preferable for better compliance and fewer adverse effects.
Iron Supplementation in Children
In a study involving anemic Kenyan school children, daily supplementation with ferrous sulfate significantly improved both appetite and growth compared to a placebo, highlighting its benefits beyond just correcting anemia.
Optimal Dosing Strategies
Daily vs. Twice Daily Dosing
The International Nutritional Anaemia Consultative Group recommends a twice daily dose of 65 mg elemental iron for pregnant women in areas with high anemia prevalence. However, a study found that a once daily dose was equally effective and had fewer side effects, making it a more practical option for many patients.
Iron Supplementation in Restless Legs Syndrome (RLS)
For patients with RLS and low ferritin levels, ferrous sulfate 325 mg taken twice daily with vitamin C has been shown to increase ferritin levels and improve RLS symptoms. However, its efficacy is limited when ferritin levels are above 75 µg/L, indicating that iron absorption is more effective in the context of low iron stores.
Drug Interactions with Ferrous Sulfate
Interaction with Levodopa
Ferrous sulfate significantly reduces the bioavailability of levodopa, a medication used in Parkinson's disease, by chelating with the drug in the gastrointestinal tract. This interaction results in a substantial decrease in peak levodopa levels and overall drug absorption, which could impact the clinical management of Parkinson's disease.
Interaction with Methyldopa
Similarly, ferrous sulfate decreases the absorption and efficacy of methyldopa, a medication used to treat hypertension. This interaction leads to increased blood pressure in patients, necessitating careful monitoring and potential adjustment of antihypertensive therapy when co-administered with ferrous sulfate.
Adverse Effects and Tolerability
Comparison with Other Iron Preparations
A study comparing conventional ferrous sulfate tablets with a wax-matrix iron preparation found that the latter had significantly fewer gastrointestinal side effects. This suggests that alternative formulations of iron supplements may improve patient tolerance and adherence to treatment.
Iron Supplementation in Cancer Patients
In cancer patients with mild iron deficiency anemia, ferrous bisglycinate chelate was found to have similar efficacy to ferrous sulfate but with potentially lower gastrointestinal toxicity. This makes it a viable alternative for patients who experience adverse effects with conventional ferrous sulfate.
Conclusion
Ferrous sulfate 325 mg tablets are an effective treatment for iron deficiency anemia across various populations, including CKD patients, pregnant women, and children. While once daily dosing is generally effective and better tolerated, twice daily dosing may be necessary in certain cases. Clinicians should be aware of significant drug interactions with medications like levodopa and methyldopa. Alternative iron formulations may offer improved tolerability for some patients.
Sources and full results
Most relevant research papers on this topic